Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/07/070116
CTRI/2024/07/070116
Not yet recruiting
Phase 2

Comparative clinical study on the efficacy of Habb-e-Mafasil with Roghan-e-Banafsha and Habb-e-Gul-e-Aakh with Roghan-e-Haft Barg in Waja'ur Rukbah (Knee Osteoarthritis)- A Randomized Clinical trial - NI

ational Institute of Unani Medicine, Bengaluru0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Unani Medicine, Bengaluru
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
ational Institute of Unani Medicine, Bengaluru

Eligibility Criteria

Inclusion Criteria

  • •1\.Diagnosed cases of OA Knee Joint as per ACR Criteria16 (clinical, radiographical and laboratory).
  • •2\.Subjects of all genders aged 45\-70 years.
  • •3\.Grade I and II of Kellgren Lawrence grading scale17

Exclusion Criteria

  • •1\.Subjects who experience a rapid worsening of knee symptoms, have a hot swollen knee, have a previous knee replacement on the affected knee, have a history of significant trauma to the affected knee, have a joint injection or arthroscopy in the past 6 months, or have any major surgery in the last year.
  • •2\.Subjects currently taking, or in the past 3 months were taking, pain\-relieving medications (e.g., nonsteroidal anti\-inflammatory drugs, analgesics, and corticosteroids).
  • •3\.Subjects diagnosed with gout or pseudo gout within the last 3 months, have a history of gout in the knee joint, diagnosed with other inflammatory arthritis (e.g., rheumatoid arthritis, septic arthritis), and malignancy, diagnosed with a complex pain disorder or severe immobility (e.g., complex regional pain syndrome, severe back pain, multiple sclerosis, muscular dystrophy, Parkinson’s disease, or hemiplegia).
  • •4\.Participants with a recent diagnosis of, and/or currently suffering from uncontrolled medical conditions including but not limited to diabetes (RBS\=180mg/dl), hypertension (\=140/90mmHg), cardiovascular disease gall bladder disease/gallstones/biliary disease, endocrine disease, or malignancies.
  • •5\.Pregnant and lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
To compare the effect of Bharangimoola arka and Tamboolapatra arka when given as nebulization and understand which one is more effecient in the attack of Tamaka swasa in childreHealth Condition 1: null- Tamaka Swasa (Bronchial Asthama)
CTRI/2017/07/008986Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital30
Not yet recruiting
Phase 2
Study on Bhoomyamlaki Churna and Chandana Churna in the management of Asrigdara w.s.r to menorrhagia and metrorrhagia
CTRI/2024/08/072148Mansarovar Ayurvedic Medical College Hospital and Research Centre
Completed
Not Applicable
Ayurvedic management of diabetic polyneuropathy.Health Condition 1: E084- Diabetes mellitus due to underlying condition with neurological complicationsHealth Condition 2: E114- Type 2 diabetes mellitus with neurological complications
CTRI/2022/04/041700J s ayurveda mahavidyalaya30
Not yet recruiting
Phase 2
To study the effect of kashaya and snehana and swedana at chest region in the treatment of bronchial asthma
CTRI/2021/08/036014DrJayanti Dutta
Not yet recruiting
Phase 2
Study on efficacy of Habbe Asgandh in Waja ul Rukba (knee arthralgia)
CTRI/2020/08/027058ZVM Unani Medical College and Hospital